EBRCZ
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was incorporated in 2003 and is based in Sunnyvale, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $2M | -$23M |
| 2025 Q4 | -0.03 | $950,580 | $52.7B |
| 2025 Q3 | -0.03 | $512M | -$26.8B |
| 2025 Q2 | -0.03 | $169,704 | -$12M |
| 2025 Q1 | -0.03 | $0 | -$13.6B |
| 2024 Q4 | -0.03 | $0 | -$11M |
| 2024 Q3 | -0.03 | $0 | -$10M |
| 2024 Q2 | -0.04 | $0 | -$10M |